On August 30, 2022 Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") and machine learning (ML) platform to transform the cost, pace, and timeline of oncology drug discovery and development, reported that the Company’s CEO & President, Panna Sharma, will be speaking at H.C. Wainwright’s 24th Annual Global Investment Conference, which is being held September 12-14, 2022 in New York, NY (Press release, Lantern Pharma, AUG 30, 2022, View Source [SID1234618776]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Further information on this conference, including registration links, can be found below:
H.C. Wainwright’s 24th Annual Global Investment Conference
September 12-14, 2022 @ Lotte New York Palace Hotel – New York, NY
Presentation Information: Lantern Pharma’s on-demand presentation will be live starting on Monday, September 12, 2022 at 7:00am EDT
Presenter: Panna Sharma, CEO & President, Lantern Pharma Inc.
Registration Link: www.hcwevents.com/annualconference
Webcasting Link: View Source